Studies related to Risk of Stroke and Coenzyme Q10

Effect Of Coenzyme Q10 On Risk Of Atherosclerosis In Patients With Recent Myocardial Infarction

Effect Decrease
Values Number and percentage. COQ10: 0 B-vitamin: 2 (2.8)
Trial Design Randomized trial
Trial Length 6+ Months
Number of Subjects 144
Sex Both Genders
Notes for this study:
In a randomized, double-blind, controlled trial, 144 participants with recent myocardial infarctions took 120 mg of coq10 daily or a b-vitamin supplement daily for one year.

The group that received coenzyme q10 saw a statistically significantly greater increase in vitamins E and C, a greater reduction in TBARS, malondialdehyde, and diene conjugates with a greater increase in HDL but not total cholesterol or LDL.

There wasn't a statistically significant difference in sudden cardiac death, fatal myocardial infarction, or total cardiac deaths, and stroke, though the coq10 group experienced fewer of each. There was a statistically significant reduction in non-fatal myocardial infarction.
Funding issues for this study:
"Acknowledgements are due to Tishcon Corporation, Westbury, New York and Centre of Nutrition and Heart, Moradabad, India."